Publication | Closed Access

Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report

Endocrine OncologyMedicineGynecologyAromataseSecond-line Hormonal TreatmentPharmacologyAromatase Inhibitor AnastrozoleEndocrine-related CancerCase Report